Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2164
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding ; volume:13 ; number:1 ; day:31 ; month:7 ; year:2012 ; pages:1-19 ; date:12.2012
BMC genomics ; 13, Heft 1 (31.7.2012), 1-19, 12.2012
- Urheber
-
Zhu, Zhou
- Beteiligte Personen und Organisationen
-
Shi, Manli
Hu, Wenyue
Estrella, Heather
Engebretsen, Jon
Nichols, Tim
Briere, David
Hosea, Natilie
Los, Gerrit
Rejto, Paul A.
Fanjul, Andrea
SpringerLink (Online service)
- DOI
-
10.1186/1471-2164-13-355
- URN
-
urn:nbn:de:1111-2016072835796
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhu, Zhou
- Shi, Manli
- Hu, Wenyue
- Estrella, Heather
- Engebretsen, Jon
- Nichols, Tim
- Briere, David
- Hosea, Natilie
- Los, Gerrit
- Rejto, Paul A.
- Fanjul, Andrea
- SpringerLink (Online service)
Ähnliche Objekte (12)
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
6 Small-Molecule Motion
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Small-molecule modifiers for DNA nanostructures
Cyclobutanes in Small‐Molecule Drug Candidates
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Pharmacological validation and characterization of small-molecule toll-like receptor 2 and 8 antagonists as modulators of inflammation
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
6 Small-Molecule Motion
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Small-molecule modifiers for DNA nanostructures
Cyclobutanes in Small‐Molecule Drug Candidates
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Pharmacological validation and characterization of small-molecule toll-like receptor 2 and 8 antagonists as modulators of inflammation
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
Small-molecule inhibitors of protein-protein interactions
Small‐Molecule Inhibitors of DNA Polymerase Function
Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction
6 Small-Molecule Motion
Androgen-regulation of sepsis response : beneficial role of androgen receptor antagonists
Small-molecule modifiers for DNA nanostructures
Cyclobutanes in Small‐Molecule Drug Candidates
Small‐Molecule Activation by Heteroleptic Metallasilylenes
Small-Molecule Targets in Tumor Immunotherapy
Pharmacological validation and characterization of small-molecule toll-like receptor 2 and 8 antagonists as modulators of inflammation
Small-Molecule Donor/Polymer Acceptor Type Organic Solar Cells: Effect of Terminal Groups of Small-Molecule Donors
Small-molecule inhibitors of protein-protein interactions